Table 1: Overview of key postoperative VTE risk factors and their underlying pathophysiological mechanisms.
|
Category |
Specific Factor |
Evidence / Association |
Pathophysiologic Rationale |
|
Strong, Consistent Patient Factors |
Prior VTE |
25‑fold ↑ risk [37] |
Persistent hypercoagulability; always triggers pharmacological prophylaxis. |
|
|
Factor V Leiden / thrombophilia |
20–24× ↑ risk [2,15] |
Inherited pro‑thrombotic state → activates coagulation cascade. |
|
|
Active / recent cancer |
Up to 12.5 % DVT despite prophylaxis [16] |
Tumour tissue factor, chemo‑induced endothelial injury & hypercoagulability. |
|
|
Diabetes mellitus |
OR ≈ 15 [30]; confirmed in newer cohorts |
Endothelial dysfunction, ↑ tissue factor, poor wound healing → stasis. |
|
|
Chronic immobilisation (cast ≥ 2‑8 wk, NWB) |
9× ↑ risk for 2-8 week immobilisation [25]; absolute DVT ≈ 2 % [64] |
Venous stasis from loss of calf‑pump action. |
|
Moderate‑Strength Patient Factors |
Advanced age (≥ 65 y) |
Mean age difference ≈ 15 y [9] |
Venous stasis, comorbidity burden, longer hospital stay. |
|
|
Cardiovascular disease (HTN, CAD) |
Meta‑analyses show ↑ risk; HF data mixed |
Systemic inflammation, ↑ fibrinogen/D‑dimer, endothelial dysfunction. |
|
|
Elevated BMI (≥ 30 kg m2) |
Large cohort (22 500 pts) → major risk; smaller studies inconsistent |
↑ Intra‑abdominal pressure → stasis; low‑grade inflammation. |
|
|
COPD |
Significant ↑ VTE below‑knee ortho surgery [19] |
Systemic inflammation, longer LOS, hypoxia‑induced coagulopathy. |
|
|
Female sex (context‑dependent) |
Modest ↑ risk in some databases; others neutral |
Estrogen exposure, varicose veins, peri‑partum status. |
|
|
Hormonal therapy (OCP/HRT) |
4× ↑ risk within 3 mo [15] |
Estrogen ↑ pro‑coagulant proteins & PAI‑1, ↓ protein S. |
|
Surgical / Peri‑operative Factors |
Hind‑ / ankle / tibial procedures vs forefoot |
OR 1.7–2.5; highest incidence mid‑/hindfoot [3] |
More tissue dissection, longer immobilisation. |
|
|
Achilles tendon rupture |
Symptomatic VTE 6.5× higher [52] |
Local inflammation adjacent to deep veins. |
|
|
Prolonged operative time (> 120 min) |
Linear ↑ [74]; FA data mixed |
Extended stasis, inflammatory activation. |
|
|
General anaesthesia (vs regional) |
OR ≈ 2-3 in some FA cohorts; data mixed |
↓ Cardiac output, venous dilatation, platelet activation. |
|
|
Non‑weight‑bearing first postoperative week |
4.3× ↑ DVT if unable to bear < 50 % body-weight on injured limb [67] |
Inadequate calf‑pump activation. |
|
|
Open fractures / complex distal tibia fixation |
Higher PE risk OR 1.6; VTE 3.3% [10] |
Greater soft‑tissue injury & surgical duration. |